Correction: Comparing regional brain uptake of incretin receptor agonists after intranasal delivery in CD-1 mice and the APP/PS1 mouse model of Alzheimer’s disease

Correction: Alz Res Therapy 16, 173 (2024)

https://doi.org/10.1186/s13195-024-01537-1

Following the publication of the original article [1], the authors identified one of the peptides used in this paper was incorrectly listed. Instead of “dulaglutide”, the peptide should be referred to as “dulaglutide bioactive fragment (BAF)”. All occurrences of “dulaglutide” in the article have been corrected accordingly.

The original article [1] has been updated.